Drug Profile
Rosiptor - Neurogene Inc
Alternative Names: AQX 1125; Rosiptor acetateLatest Information Update: 26 Dec 2023
Price :
$50
*
At a glance
- Originator Aquinox Pharmaceuticals
- Class Androstanes; Anti-inflammatories; Immunotherapies; Indenes; Small molecules
- Mechanism of Action Inositol-1,4,5-trisphosphate 5-phosphatase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic asthma; Atopic dermatitis; Chronic obstructive pulmonary disease; Haematological disorders; Hypersensitivity; Immunological disorders; Inflammation; Interstitial cystitis; Irritable bowel syndrome; Prostatitis; Pulmonary fibrosis